Cirtran Corp (CIRX)
OTHER OTC:CIRX
Want to see CIRX full AI Analyst Report?
Top Page
Cirtran
(OTC:CIRX)
Select Model
Select Model
Rating:52Neutral
Price Target:
$0.05
▲(155.00% Upside)
Action:Reiterated
Date:06/12/26
The score is held down primarily by very weak financial performance—negative equity, negative operating profitability, and negative free cash flow—despite improved revenue growth and a recent swing to positive net income. Technicals are moderately supportive with price above key moving averages and positive momentum. Valuation appears very low on P/E, but quality concerns and lack of dividend support limit the benefit.
Positive Factors
Revenue Growth Momentum
Sustained TTM revenue growth of +22.4% indicates improving demand and top-line traction versus prior volatile years. Durable revenue momentum can support scale economies, improve operating leverage over time, and provide a platform to convert sales growth into lasting profitability if management sustains execution.
Negative Factors
Deep Negative Equity
A ~-$22.9M equity deficit is a structural capital impairment that undermines solvency and access to conventional funding. Persistent negative shareholders’ equity increases refinancing and counterparty risk, likely forces dilutive capital raises or restructuring, and materially limits strategic optionality over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth Momentum
Sustained TTM revenue growth of +22.4% indicates improving demand and top-line traction versus prior volatile years. Durable revenue momentum can support scale economies, improve operating leverage over time, and provide a platform to convert sales growth into lasting profitability if management sustains execution.
Read all positive factors
Cirtran (CIRX) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$247.27K
Dividend YieldN/A
Average Volume (3M)12.02K
Price to Earnings (P/E)0.1
Beta (1Y)-1.51
Revenue Growth188.16%
EPS GrowthN/A
CountryUS
Employees4
SectorIndustrials
Sector Strength72
IndustryConglomerates
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,945,417
10 Day Avg. Volume9,745
30 Day Avg. Volume12,017
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.07
P/FCF Ratio-0.16
Enterprise Value/Market Cap14.95
Enterprise Value/Revenue0.97
Enterprise Value/Gross Profit2.13
Enterprise Value/Ebitda-20.91
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cirtran Business Overview & Revenue Model
Company Description
Established in 1987 and headquartered in Las Vegas, Nevada, CirTran Corporation furnishes a full spectrum of manufacturing, marketing, distribution, and technological solutions. The firm's global operations are centered on consumer products, parti...
How the Company Makes Money
null...
Cirtran Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
14
Very Negative
Cash Flow
22
Negative
| Breakdown | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.13M | 1.30M | 1.62M | 1.72M | 2.92M |
| Gross Profit | 1.54M | 838.64K | 1.01M | 1.02M | 1.90M |
| EBITDA | -127.92K | -1.75M | 221.70K | -562.15K | -126.73K |
| Net Income | -701.63K | -2.63M | 20.29M | -1.35M | -627.38K |
Balance Sheet | |||||
| Total Assets | 2.51M | 1.53M | 1.85M | 2.00M | 1.46M |
| Cash, Cash Equivalents and Short-Term Investments | 9.59K | 30.38K | 0.00 | 18.08K | 5.47K |
| Total Debt | 3.43M | 3.36M | 3.22M | 3.16M | 3.22M |
| Total Liabilities | 27.62M | 25.94M | 23.63M | 44.07M | 42.03M |
| Stockholders Equity | -25.11M | -24.41M | -21.78M | -42.07M | -40.56M |
Cash Flow | |||||
| Free Cash Flow | -1.34M | -46.35K | -81.02K | 159.30K | 340.66K |
| Operating Cash Flow | -1.34M | -46.35K | -72.61K | 159.30K | 344.46K |
| Investing Cash Flow | 0.00 | 15.40K | -8.41K | 0.00 | -3.80K |
| Financing Cash Flow | 1.35M | 30.95K | 62.94K | -146.69K | -443.33K |
Cirtran Risk Analysis
Cirtran disclosed 16 risk factors in its most recent earnings report. Cirtran reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Cirtran Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $145.96M | -2.06 | -27.50% | ― | -69.74% | 63.94% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | $147.24M | -4.06 | -22.42% | ― | -3.08% | -9.56% | |
52 Neutral | $247.27K | 0.15 | ― | ― | 188.16% | ― | |
51 Neutral | $499.04M | 295.22 | 0.36% | ― | 19.20% | -21.40% | |
50 Neutral | $760.64M | ― | -46.27% | 20.53% | 7.52% | -1.67% | |
50 Neutral | $186.97M | 12.56 | 37.76% | ― | 9.30% | 22.99% |
* Industrials Sector Average
CIRX
Cirtran
0.05
0.04
354.55%
CODI
Compass Diversified Holdings
10.11
3.70
57.72%
NNBR
NN
2.79
0.75
36.76%
RCMT
Rcm Technologies
26.38
3.90
17.35%
TRC
Tejon Ranch Company
18.48
1.68
10.00%
TUSK
Mammoth Energy Services
3.03
0.07
2.36%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.